Quick Takeaways
- Stonepine Capital Management, LLC filed SCHEDULE 13G/A for Kezar Life Sciences, Inc. Common Stock (KZR).
- Disclosed ownership: 2.1%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"Stonepine Capital Management, LLC disclosed 2.1% ownership in Kezar Life Sciences, Inc. Common Stock (KZR) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 2.1% | 156,179 | 0 | 156,179 | /s/ Jon M. Plexico | Managing Member | |
| Stonepine Capital, L.P. | 2.1% | 156,179 | 0 | 156,179 | /s/ Jon M. Plexico | Managing Member of the General Partner, Stonepine GP, LLC | |
| Stonepine GP, LLC | 2.1% | 156,179 | 0 | 156,179 | /s/ Jon M. Plexico | Managing Member | |
| Jon M. Plexico | 2.1% | 156,179 | 0 | 156,179 | /s/ Jon M. Plexico | Reporting person |